Article – Dechert LLP: Medicinal Cannabis in the UK: Fund Structuring, Investment and Listing Considerations
Cannabis Law Report
JULY 23, 2021
The FCA guidance does not expressly capture non-medicinal (and non-recreational) cannabis companies, for example “wellness” companies supplying CBD oils and tinctures (which are low in Tetrahydrocannabinol [THC], the principal psychoactive constituent of cannabis). 1, MDR 2001. Section 16A MDR 2001. 5 MDR 2001: [link].
Let's personalize your content